Showing results (991-1000 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 1, 1990
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancerG Falkson, M R Chasen, H C FalksonInvestigational New Drugs|March 31, 2011
Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genesBerta Otová, Iwao Ojima, Radka Václavíková, et al.Investigational New Drugs|May 1, 1990
A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-injection scheduleC J Allegra, J Jenkins, R B Weiss, et al.Investigational New Drugs|August 1, 1990
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group studyE A Eisenhauer, K I Pritchard, D J Perrault, et al.Investigational New Drugs|April 16, 2011
A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifenDennis Ma, Phillip Tremblay, Kevinjeet Mahngar, et al.Investigational New Drugs|April 16, 2011
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemiaH M Kantarjian, S Padmanabhan, W Stock, et al.Investigational New Drugs|April 27, 2011
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemiaSimona Lapusan, Maria B Vidriales, Xavier Thomas, et al.Investigational New Drugs|April 13, 2011
A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumorsAkira Fukutomi, Kiyohiko Hatake, Kaoru Matsui, et al.Investigational New Drugs|April 13, 2011
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)Beate Schultheis, Dirk Strumberg, Lothar Bergmann, et al.Investigational New Drugs|May 4, 2011
Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cellsCoral O Omene, Jing Wu, Krystyna FrenkelPageof 372